Clinical Trial

Diagnostic Study for Differentiating Functional From Organic Diseases in Patients With Lower GIT Symptoms

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2025 (before its estimated December 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study is intended to find a new trusted, cost-effective biomarker for differentiating irritable bowel syndrome from inflammatory bowel disease to decrease the use of unnecessary invasive methods in patients with irritable bowel syndrome
Trial Details
NCT Number NCT07016529
Lead Sponsor Sohag University
Conditions Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD)
Enrollment 100 participants
Start Date 2025-06-10
Primary Completion 2025-12-10 (estimated)
Study Completion 2025-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-06-11